Symbiotec Pharmalab receives US FDA EIR for Pithampur facility with VAI status
Reuters reports Symbiotec Pharmalab Limited received a US FDA EIR for its Pithampur facility with VAI status.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
Symbiotec Pharmalab Receives U.S. FDA Eir For Pithampur Facility With Vai Status
Symbiotec Pharmalab Limited NSE:SYMBIOTEC